Skip to content Skip to footer

CVS and Walgreens Will Start Selling Abortion Pills This Month

Eventually, both pharmacies will make mifepristone available in all states where abortion is legal.

In this photo illustration, a bottle of Misoprostol tablets are displayed at a family planning clinic on April 13, 2023, in Rockville, Maryland.

CVS and Walgreens will start dispensing mifepristone, one of the medications used to induce an abortion, in stores this month.

The news was first reported by The New York Times. It comes more than a year after both retail pharmacy chains, the nation’s two largest, said they would pursue certification from the Food and Drug Administration (FDA) to dispense the pill.

Mifepristone can be used in conjunction with another medication, misoprostol, to induce an abortion at home. A vast body of research shows it is safe and highly effective, particularly in the first trimester of pregnancy. Patients seeking mifepristone need a prescription from a medical provider. Misoprostol is already available in pharmacies for patients with a prescription.

The chains will start dispensing mifepristone in a few states: CVS in Rhode Island and Massachusetts, and Walgreens in California, Illinois, Massachusetts, New York and Pennsylvania. Eventually, both pharmacies will make it available in all states where abortion is legal and where they are permitted to do so. Neither chain will dispense the pill through the mail.

CVS pharmacies will begin filling prescriptions “in the weeks ahead,” said Amy Thibault, a company spokesperson. Walgreens anticipates beginning to dispense mifepristone in the next week, per spokesperson Fraser Engerman.

Mifepristone received FDA approval more than 20 years ago, but the ability to dispense it has been tightly regulated — regulations stemming, physicians and researchers have said, from the political controversy associated with making the pill available. For years, the drug had to be dispensed in person and under the supervision of a specially certified clinician. But in recent years, regulators have pushed to make the drug more available.

In December 2021, the FDA allowed specialty pharmacies to disperse mifepristone over mail. And in January 2023, the FDA issued guidance that would allow brick-and-mortar pharmacies to provide the medication. Medical organizations including the American College of Obstetricians and Gynecologists had long called for the change, noting the large body of medical evidence showing the drug’s safety.

Medication abortions make up the majority of pregnancy terminations performed in the United States.

Since Roe v. Wade’s fall, medication abortion has emerged as a top target for the anti-abortion movement. Abortion opponents have pushed for laws restricting its use, in particular the option for it to be provided through the mail. The U.S. Supreme Court this month will hear a case challenging mifepristone’s availability.

The case, filed in Texas, originally explored whether the drug should be taken off the market completely. But the high court is instead weighing a narrower set of questions: whether to block the 2016 FDA decision that allowed doctors to prescribe it virtually and that expanded approval of the drug from use in the first seven weeks of pregnancy to the first 10.

If the drug is approved for only the first seven weeks of pregnancy, doctors could still recommend it past that point, through what’s called an “off-label” prescription. But there would be no such workaround for a decision rescinding the federal telemedicine approval. Meanwhile, evidence shows that more Americans are relying on a virtual option: a study released this week found that about 16 percent of abortions performed in the fall of 2023 were done via telemedicine.

President Joe Biden applauded the decision by CVS and Walgreens, saying in a statement that he encourages other pharmacies to get certified to distribute mifepristone in stores and that the administration would defend the FDA’s ability to regulate the drug.

We’re not backing down in the face of Trump’s threats.

As Donald Trump is inaugurated a second time, independent media organizations are faced with urgent mandates: Tell the truth more loudly than ever before. Do that work even as our standard modes of distribution (such as social media platforms) are being manipulated and curtailed by forces of fascist repression and ruthless capitalism. Do that work even as journalism and journalists face targeted attacks, including from the government itself. And do that work in community, never forgetting that we’re not shouting into a faceless void – we’re reaching out to real people amid a life-threatening political climate.

Our task is formidable, and it requires us to ground ourselves in our principles, remind ourselves of our utility, dig in and commit.

As a dizzying number of corporate news organizations – either through need or greed – rush to implement new ways to further monetize their content, and others acquiesce to Trump’s wishes, now is a time for movement media-makers to double down on community-first models.

At Truthout, we are reaffirming our commitments on this front: We won’t run ads or have a paywall because we believe that everyone should have access to information, and that access should exist without barriers and free of distractions from craven corporate interests. We recognize the implications for democracy when information-seekers click a link only to find the article trapped behind a paywall or buried on a page with dozens of invasive ads. The laws of capitalism dictate an unending increase in monetization, and much of the media simply follows those laws. Truthout and many of our peers are dedicating ourselves to following other paths – a commitment which feels vital in a moment when corporations are evermore overtly embedded in government.

Over 80 percent of Truthout‘s funding comes from small individual donations from our community of readers, and the remaining 20 percent comes from a handful of social justice-oriented foundations. Over a third of our total budget is supported by recurring monthly donors, many of whom give because they want to help us keep Truthout barrier-free for everyone.

You can help by giving today. Whether you can make a small monthly donation or a larger gift, Truthout only works with your support.